Lemtrada ‘a permanent therapy’ claims doctor

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Lemtrada ‘a permanent therapy’ claims doctor

Post by MSUK » Mon Jun 01, 2015 5:27 am

Speaking at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis, Indiana, Mr Samuel F. Hunter, MD, PhD, president of the Advanced Neurosciences Institute in Franklin, Tennessee, gave a presentation on outcomes in patients with relapsing multiple sclerosis (MS) treated with Lemtrada (alemtuzumab)......... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/

User avatar
CureOrBust
Family Elder
Posts: 3361
Joined: Wed Jul 27, 2005 2:00 pm
Location: Sydney, Australia

Re: Lemtrada ‘a permanent therapy’ claims doctor

Post by CureOrBust » Mon Jun 01, 2015 5:27 pm

In CARE-MS I, Lemtrada was significantly more effective than interferon beta-1a at reducing annualized relapse rates; the difference observed in slowing disability progression did not reach statistical significance. In CARE-MS II, Lemtrada was significantly more effective than interferon beta-1a at reducing annualized relapse rates, and accumulation of disability was significantly slowed in patients given Lemtrada vs. interferon beta-1a.
Can someone explain to me the difference between "slowing disability progression" and "accumulation of disability"? :? How can one reach statistical significance and the other not?

Anunymouse
Family Member
Posts: 75
Joined: Thu Sep 04, 2014 10:07 pm

Re: Lemtrada ‘a permanent therapy’ claims doctor

Post by Anunymouse » Mon Oct 12, 2015 8:39 pm

I'm still trying to figure out why aubagio claims that begin 7% better than placebo is "significant".

User avatar
NHE
Volunteer Moderator
Posts: 5214
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Re: Lemtrada ‘a permanent therapy’ claims doctor

Post by NHE » Mon Oct 12, 2015 9:58 pm

CureOrBust wrote:
In CARE-MS I, Lemtrada was significantly more effective than interferon beta-1a at reducing annualized relapse rates; the difference observed in slowing disability progression did not reach statistical significance. In CARE-MS II, Lemtrada was significantly more effective than interferon beta-1a at reducing annualized relapse rates, and accumulation of disability was significantly slowed in patients given Lemtrada vs. interferon beta-1a.
Can someone explain to me the difference between "slowing disability progression" and "accumulation of disability"? :? How can one reach statistical significance and the other not?
They are discussing two different studies, CARE-MS I and CARE-MS II.

User avatar
CureOrBust
Family Elder
Posts: 3361
Joined: Wed Jul 27, 2005 2:00 pm
Location: Sydney, Australia

Re: Lemtrada ‘a permanent therapy’ claims doctor

Post by CureOrBust » Tue Oct 13, 2015 12:40 am

Ah, that learn me for skim reading.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post